Students in leadership positions learn about brain tumors and gain real world experience in running a non-profit business while raising funds for brain tumor research. Beneficiaries of the money we raise are Barrow Neurological Institute, National Brain Tumor Society, Phoenix Childrens Hospital, Steele Childrens Research Center in Tucson, and Translational Genomics Research Institute (TGen). With your help we can make a difference. The intent of our website is to further our objectives of disseminating information about this disease process, stimulating more widespread involvement within our community through donating, volunteering and participating in one or more of our events, and publicizing and promoting this exceptional student-run organization.

"Be the change you wish to see in the world..." Gandhi

Thanks for visiting. Your support is greatly appreciated.

SSBTR in the News


Philanthropic "Quotes"

  • “Not he who has much is rich but he who gives much.”

  • “We are responsible for the world in which we find ourselves, if only because we are the only sentient force that can change it.”

  • “You give but little when you give of your possessions. It is when you give of yourself that you truly give.”



Brain Tumor News

  • Researchers have identified a unique metabolic signature associated with epileptic brain tissue that causes seizures. The chemical biomarker can be detected noninvasively using technology based on magnetic resonance imaging.

  • Patient benefits by a new piece of equipment, a “positioning board” that allows for even more precise targeting of tumors, as part of radiation therapy in the Gainesville-based Northeast Georgia Health System.

  • Experimental Brain Cancer Therapy Harnesses Stem Cells, Cold Virus

    A phase 1 clinical trial is exploring an investigational neural stem cell therapy for the treatment of brain cancer. This approach combines stem cell therapy with a common cold virus and has been observed to target and kill aggressive brain cancer cells, according to a press release from Northwestern Medicine.

  • Early phase Northwestern Medicine research has demonstrated a potential new therapeutic strategy for treating deadly glioblastoma brain tumors. The strategy involves using lipid polymer-based nanoparticles to deliver molecules to the tumors, where the molecules shut down key cancer drivers called brain tumor-initiating cells (BTICs).

  • The team has developed cancer-killing viruses that can deliver stem cells via the carotid artery, and applied them to metastatic tumors in the brains of clinically relevant mouse models.

blank line

SSBTR in the News

© Copyright 2017